Wolverine Trading’s SkinHealth Systems SKIN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-14,900
Closed -$23.8K 5715
2024
Q4
$23.8K Sell
14,900
-5,200
-26% -$8.17K ﹤0.01% 5088
2024
Q3
$27.7K Buy
20,100
+9,800
+95% +$16.1K ﹤0.01% 4602
2024
Q2
$19.8K Sell
10,300
-28,300
-73% -$79.7K ﹤0.01% 4327
2024
Q1
$171K Buy
38,600
+11,000
+40% +$35.7K ﹤0.01% 3871
2023
Q4
$85.8K Sell
27,600
-17,100
-38% -$64.2K ﹤0.01% 4136
2023
Q3
$269K Buy
44,700
+33,400
+296% +$235K ﹤0.01% 3422
2023
Q2
$95.4K Sell
11,300
-2,200
-16% -$22.9K ﹤0.01% 3788
2023
Q1
$164K Sell
13,500
-81,200
-86% -$939K ﹤0.01% 3512
2022
Q4
$862K Sell
94,700
-72,000
-43% -$777K ﹤0.01% 1947
2022
Q3
$1.97M Buy
166,700
+121,400
+268% +$1.53M ﹤0.01% 1425
2022
Q2
$612K Sell
45,300
-33,500
-43% -$449K ﹤0.01% 2353
2022
Q1
$1.37M Buy
+78,800
New +$1.3M ﹤0.01% 2121
2021
Q4
Sell
-39,100
Closed -$1.02M 6741
2021
Q3
$1.02M Buy
39,100
+6,700
+21% +$147K ﹤0.01% 2955
2021
Q2
$564K Sell
32,400
-3,000
-8% -$41K ﹤0.01% 3519
2021
Q1
$371K Buy
+35,400
New +$389K ﹤0.01% 4162

Other funds holding SKIN

Wolverine Trading's SKIN Position: Q4 2024 in Review

Wolverine Trading sold out of SkinHealth Systems (SKIN) in Q4 2024, closing a stake of 16,456 shares — an estimated $25.9K sold.

Wolverine Trading first reported a position in SKIN in Q1 2021 and held it in 7 quarters. The position peaked at $1.13M in Q2 2021. 101 funds tracked by Wall St. Rank hold SKIN as of Q4 2024.

  • Wolverine Trading reported no remaining SkinHealth Systems position as of Q4 2024 after selling out during the quarter.
  • Wolverine Trading sold 16,456 SkinHealth Systems shares in Q4 2024, an estimated $25.9K.
  • Wolverine Trading first reported a position in SkinHealth Systems in Q1 2021 and held it in 7 quarters.
  • Wolverine Trading's SkinHealth Systems position peaked at $1.13M in Q2 2021.
  • 101 funds tracked by Wall St. Rank held SkinHealth Systems as of Q4 2024.

Based on Wolverine Trading's 13F filing for Q4 2024, filed 14 Feb 2025.